Le Centre hospitalier public du Cotentin est un groupe hospitalier français, situé dans les communes de Cherbourg-en-Cotentin et de Valognes. Il est issu de la réunion des deux établissements de ces communes le 1ᵉʳ avril 2006, sous la direction de l'hôpital Louis-Pasteur de Cherbourg-Octeville.

During the past decade, CH Cherbourg conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Cherbourg" #1 sponsor was "Centre Francois Baclesse" with 4 trials, followed by "Centre Leon Berard" with 2 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored, "MicroPort CRM" with 2 trials sponsored and "UNICANCER" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Cherbourg" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Canceropôle Nord Ouest" with 1 trials as a collaborator, "Fondation ARC" with 1 trials as a collaborator and "Groupement Interrégional de Recherche Clinique et d'Innovation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "CH Cherbourg" are "Breast Cancer" (2 trials), "Analgesia" (1 trials), "Atrial Arrhythmia" (1 trials), "Atrial Fibrillation" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "CH Cherbourg" in a lesser frequency.

Most popular intervention types in "CH Cherbourg" are "Drug" (7 trials), "Other" (7 trials), "Device" (4 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetylsalicylic acid + loperamide" (1 trials), "Data collection" (1 trials), "Enoxaparin" (1 trials), "FOLFOX4 or XELOX" (1 trials) and "Ialuset®" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Cherbourg" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "CH Cherbourg". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in CH Cherbourg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CH Cherbourg, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".